Serial entrepreneur, Dr. Michael Triplett, co-founder and chairman of Armatus Bio, offers tips to aspiring entrepreneurs and investors in Rev1 Ventures first Founders’ Story of 2025. This not-to-be-missed video features the remarkable leadership and journey of Triplett as well as well as a roadmap for what it takes to build a startup life-sciences company in the Midwest. Armatus Bio and Neucore Bio are Dr. Triplett’s third and fourth life sciences startups. Previously, he was co-founder, president, and CEO of Myonexus Therapeutics (acquired by Sarepta Therapeutics in 2019) and Clarametyx Biosciences, a clinical stage life sciences business that closed a $33 million Series A round last year. VIEW VIDEO